Abbott agreed to pay $160 million to settle allegations that a company previously owned by Alere submitted false claims to Medicare for diabetes supplies and paid kickbacks to Medicare beneficiaries.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,